BioCentury | May 30, 2011
Company News

Specifar Pharmaceuticals S.A., Watson deal

...AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) markets Nexium esomeprazole to treat gastroesophageal reflux disease (GERD). Specifar Pharmaceuticals S.A....
Items per page:
1 - 1 of 1
BioCentury | May 30, 2011
Company News

Specifar Pharmaceuticals S.A., Watson deal

...AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) markets Nexium esomeprazole to treat gastroesophageal reflux disease (GERD). Specifar Pharmaceuticals S.A....
Items per page:
1 - 1 of 1